Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

32.79B

Market cap32.79B

Price-Earnings ratio

12.39

Price-Earnings ratio12.39

Dividend yield

2.78%

Dividend yield2.78%

Average volume

4.24M

Average volume4.24M

High today

$80.59

High today$80.59

Low today

$78.30

Low today$78.30

Open price

$78.30

Open price$78.30

Volume

5.57M

Volume5.57M

52 Week high

$148.30

52 Week high$148.30

52 Week low

$68.77

52 Week low$68.77

Stock Snapshot

With a market cap of 32.79B, Zoetis(ZTS) trades at $80.00. The stock has a price-to-earnings ratio of 12.39 and currently yields dividends of 2.78%.

During the trading session on 2026-10-17, Zoetis(ZTS) shares reached a daily high of $80.59 and a low of $78.30. At a current price of $80.00, the stock is +2.2% higher than the low and still -0.7% under the high.

Trading volume for Zoetis(ZTS) stock has reached 5.57M, versus its average volume of 4.24M.

The stock's 52-week range extends from a low of $68.77 to a high of $148.30.

ZTS News

Simply Wall St 7h

Will Lower Earnings Outlook Change Zoetis Stock Narrative

Zoetis cut its 2026 earnings outlook after reporting softer demand in its U.S. companion-animal business, while livestock and international operations provided...

TipRanks 2d

Zoetis initiated with a Neutral at Goldman Sachs

Goldman Sachs initiated coverage of Zoetis (ZTS) with a Neutral rating and $74 price target The firm is we constructive on the company’s long-term outlook given...

Simply Wall St 4d

Zoetis Stock May Sit Below Fair Value After Mixed Q2 Results

has seen its share price weaken materially in recent years, and with earnings now in the spotlight, the question is whether the current valuation still lines up...

Analyst ratings

67%

of 18 ratings

Buy

33.3%

Hold

66.7%

Sell

More ZTS News

TipRanks 5d

Zoetis Appoints Iris Knobloch to Board of Directors

The latest update is out from Zoetis ( (ZTS) ). On October 8, 2026, Zoetis’ board appointed Iris Knobloch as a director, effective December 1, 2026, expanding...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.